<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>News and Events</title>
	<link>http://www.roboleo.com/blog</link>
	<description>The Blog of Roboleo &#38; Co</description>
	<lastBuildDate>Thu, 17 May 2012 10:43:21 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.0.1" -->

	<item>
		<title>Overiew of the challenges rega&#8230;</title>
		<description><![CDATA[Overiew of the challenges regarding VBP in UK http://t.co/VzzSVkjf via @pmlivecom]]></description>
		<link>http://www.roboleo.com/blog/news/overiew-of-the-challenges-rega/</link>
			</item>
	<item>
		<title>National Prescribing Centre no&#8230;</title>
		<description><![CDATA[National Prescribing Centre now NICE Medicines and Prescribing Centre http://t.co/wXN2Chwg]]></description>
		<link>http://www.roboleo.com/blog/news/national-prescribing-centre-no/</link>
			</item>
	<item>
		<title>OHE Research on VBP: Disease S&#8230;</title>
		<description><![CDATA[OHE Research on VBP: Disease Severity and Unmet Need in the UK due Summer 2012 http://t.co/sIJ7iI8c]]></description>
		<link>http://www.roboleo.com/blog/news/ohe-research-on-vbp-disease-s/</link>
			</item>
	<item>
		<title>Guidance on direct access to d&#8230;</title>
		<description><![CDATA[Guidance on direct access to diagnostic tests for cancer]]></description>
		<link>http://www.roboleo.com/blog/news/guidance-on-direct-access-to-d/</link>
			</item>
	<item>
		<title>RT @pharmaphorum: “&#8230;a succ&#8230;</title>
		<description><![CDATA[RT @pharmaphorum: “&#8230;a successful HTA does not guarantee uptake of your new drug .” http://t.co/XjDcfrGd #pharma #market access]]></description>
		<link>http://www.roboleo.com/blog/news/rt-pharmaphorum-%e2%80%9c-a-succ/</link>
			</item>
	<item>
		<title>How can you exploit successful&#8230;</title>
		<description><![CDATA[How can you exploit successful market access strategies? &#124; pharmaphorum: http://t.co/WMBwOOWy]]></description>
		<link>http://www.roboleo.com/blog/news/how-can-you-exploit-successful/</link>
			</item>
	<item>
		<title>Health and Social Care Bill passes final hurdle</title>
		<description><![CDATA[Thanks to Lexcomm for this summary of the Bill Commissioning in a reformed NHS The central part of the Government’s NHS reforms – the introduction of Clinical Commissioning Groups (CCGs) – has focussed on transferring commissioning away from largely managerial</a>]]></description>
		<link>http://www.roboleo.com/blog/news/health-and-social-care-bill-passes-final-hurdle/</link>
			</item>
	<item>
		<title>Roche cutting price, rebrandin&#8230;</title>
		<description><![CDATA[Roche cutting price, rebranding Herceptin, MabThera in India &#124; FirstWord Pharma http://t.co/wp3RotT6 via @fwpharma]]></description>
		<link>http://www.roboleo.com/blog/news/roche-cutting-price-rebrandin/</link>
			</item>
	<item>
		<title>Two thirds of EU and US pharma&#8230;</title>
		<description><![CDATA[Two thirds of EU and US pharma execs say business model &#8216;is broken&#8217; http://t.co/pbia3Umw via @pmlivecom]]></description>
		<link>http://www.roboleo.com/blog/news/two-thirds-of-eu-and-us-pharma/</link>
			</item>
	<item>
		<title>German Pricing Mechanism Adds &#8230;</title>
		<description><![CDATA[German Pricing Mechanism Adds Weak Economies, Could Spell Trouble For EU Industry http://t.co/5QcNMPy4]]></description>
		<link>http://www.roboleo.com/blog/news/german-pricing-mechanism-adds/</link>
			</item>
</channel>
</rss>

